Silver Spike Investment Corp SSIC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $11.48
- Day Range
- $11.35–11.63
- 52-Week Range
- $7.29–11.66
- Bid/Ask
- $11.34 / $12.17
- Market Cap
- $70.54 Mil
- Volume/Avg
- 2,860 / 18,186
Key Statistics
- Price/Earnings (Normalized)
- 10.00
- Price/Sales
- 5.68
- Dividend Yield (Trailing)
- 6.38%
- Dividend Yield (Forward)
- 8.74%
- Total Yield
- 6.38%
Company Profile
Silver Spike Investment Corp is a closed-end, non-diversified management investment company. Its objective is investing primarily in secured debt, unsecured debt, equity warrants and direct equity investments in private leveraged middle-market cannabis companies and other companies in the health and wellness sector.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- —
- Website
- https://www.silverspikecap.com
Comparables
Valuation
|
Metric
|
SSIC
|
FINN
|
TRUL
|
|---|---|---|---|
Price/Earnings (Normalized) | 10.00 | — | 71.66 |
Price/Book Value | 0.84 | — | 1.62 |
Price/Sales | 5.68 | — | 1.99 |
Price/Cash Flow | 11.37 | — | 36.96 |
Price/Earnings
SSIC
FINN
TRUL
Financial Strength
|
Metric
|
SSIC
|
FINN
|
TRUL
|
|---|---|---|---|
Quick Ratio | — | — | 2.82 |
Current Ratio | — | — | 4.99 |
Interest Coverage | — | — | −2.51 |
Quick Ratio
SSIC
FINN
TRUL
Profitability
|
Metric
|
SSIC
|
FINN
|
TRUL
|
|---|---|---|---|
Return on Assets (Normalized) | 6.12% | 0.95% | −3.80% |
Return on Equity (Normalized) | 6.31% | 11.53% | −7.03% |
Return on Invested Capital (Normalized) | — | — | −2.14% |
Return on Assets
SSIC
FINN
TRUL
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Dxrbvxrj | Xmngv | $79.1 Bil | |
MKKGY
| Merck KGaA ADR | Fdjldvyz | Dxndbs | $74.3 Bil | |
HLN
| Haleon PLC ADR | Kybfgkkg | Ywmn | $38.1 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Kgysnfjx | Fwvr | $19.1 Bil | |
VTRS
| Viatris Inc | Jjtwxftt | Rnd | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Xjfrrrmz | Mlx | $11.7 Bil | |
CTLT
| Catalent Inc | Wnpbhjqnt | Zxrsl | $10.0 Bil | |
CURLF
| Curaleaf Holdings Inc | Ybmxnvplk | Rslxw | $4.2 Bil | |
PRGO
| Perrigo Co PLC | Dnqcdts | Ldbvx | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Dpsfjsdk | Zbbzdn | $3.3 Bil |